Cargando…
Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer
Under normal conditions, the immune system responds effectively to both external and internal threats without damaging healthy tissues. Cells undergoing a neoplastic transformation are one such threat. An efficient activation of T cells is enabled by T-cell receptor (TCR) interactions with antigen-p...
Autores principales: | Grywalska, Ewelina, Pasiarski, Marcin, Góźdź, Stanisław, Roliński, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177399/ https://www.ncbi.nlm.nih.gov/pubmed/30323625 http://dx.doi.org/10.2147/OTT.S150817 |
Ejemplares similares
-
Immunogenicity And Safety Of The 13-Valent Pneumococcal Conjugate Vaccine In Patients With Monoclonal Gammopathy Of Undetermined Significance – Relationship With Selected Immune And Clinical Parameters
por: Pasiarski, Marcin, et al.
Publicado: (2019) -
CAR-T Cell Therapy—An Overview of Targets in Gastric Cancer
por: Bębnowska, Dominika, et al.
Publicado: (2020) -
Current Possibilities of Gynecologic Cancer Treatment with the Use of Immune Checkpoint Inhibitors
por: Grywalska, Ewelina, et al.
Publicado: (2019) -
Exploring the Significance of Immune Checkpoints and EBV Reactivation in Antibody Deficiencies with Near-Normal Immunoglobulin Levels or Hyperimmunoglobulinemia
por: Mertowska, Paulina, et al.
Publicado: (2023) -
Programmed cell death 1 expression and Epstein-Barr virus infection in chronic lymphocytic leukaemia: a prospective cohort study
por: Grywalska, Ewelina, et al.
Publicado: (2019)